Rick Winningham | Chief Executive Officer |
Rhonda Farnum | Chief Business Officer |
Rick Graham | Head of Research and Development |
Aziz Sawaf | Chief Financial Officer |
David Risinger | Leerink |
Douglas Tsao | H.C. Wainwright |
Eva Xia Privitera | Cowen |
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to Theravance Biopharma's Second Quarter 2023 Conference Call.
During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company's formal remarks. [Operator Instructions] Also, today's conference call is being recorded.